C2003459||miR‑221
C0122111||High mobility group AT-hook 2
C0005740||bleomycin
C0034069||pulmonary fibrosis
C1704256||transforming growth factor‑β1
C0529119||Smad3
C1523298||epithelial-mesenchymal transition
C2003459||MicroRNA (miR)-221
C1523298||epithelial-mesenchymal transition
C1523298||epithelial-mesenchymal transition
C0122111||High mobility group AT-hook 2
C0122111||High mobility group AT-hook 2
C1523298||epithelial-mesenchymal transition
C2003459||miR‑221
C0034069||pulmonary fibrosis
C2003459||miR‑221
C0122111||High mobility group AT-hook 2
C0017262||expression
C1537859||miR‑221
C0122111||High mobility group AT-hook 2
C0086418||human
C1800706||idiopathic pulmonary fibrosis
C1800706||idiopathic pulmonary fibrosis
C0040300||tissues
C0024109||pulmonary
C0007634||cells
C0001418||adenocarcinoma
C4277577||A549
C0086418||human
C0599333||bronchial epithelium
C0599333||human bronchial epithelium
C0682523||cell lines
C0017262||expression
C1537859||miR‑221
C0040300||tissues
C0007634||cells
C0035696||mRNA
C1171362||protein expression
C0122111||High mobility group AT-hook 2
C1704256||transforming growth factor‑β1
C1704256||transforming growth factor‑β1
C1523298||epithelial-mesenchymal transition
C0041904||upregulated
C0600223||expression
C0017393||mesenchymal markers
C0027215||N‑cadherin
C0042666||vimentin
C2716282||α‑smooth muscle actin
C0041455||collagen I
C0009332||collagen III
C0013081||downregulated
C0600223||expression
C0017393||epithelial marker
C0042172||E-cadherin
C4277577||A549
C0014597||HBE cells
C0314641||transfection
C2003459||miR‑221
C1171362||expression
C1158886||phosphorylated
C0529119||Smad3
C1537859||miR‑221
C0017262||overexpressing
C0007634||cells
C0013081||downregulated
C1704256||transforming growth factor‑β1
C0007634||cells
C0314641||transfection
C0017262||overexpression
C1537859||miR‑221
C1171362||expression
C0122111||High mobility group AT-hook 2
C1523298||epithelial-mesenchymal transition
C0596290||proliferation
C4277577||A549
C0014597||HBE cells
C0122111||High mobility group AT-hook 2
C2003459||miR‑221
C0022885||gene assay
C2986594||mouse model
C0005740||bleomycin
C0005740||bleomycin
C0034069||pulmonary fibrosis
C2744274||miR‑221
C1523298||epithelial-mesenchymal transition
C0523207||Hematoxylin and eosin staining
C0005740||bleomycin
C0225695||alveolar walls
C0009325||collagen
C2744274||miR‑221
C0034069||lung fibrosis
C0040300||tissues
C0225695||alveolar walls
C0034051||lung alveoli
C1523298||EMT process
C2744274||miR‑221
C2003459||miR‑221
C0122111||High mobility group AT-hook 2
C0005740||bleomycin
C0034069||pulmonary fibrosis
C1704256||transforming growth factor‑β1
C1566798||Smad3
C0037080||signaling pathway